Skip to main content

Justin Trojanowski

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Justin Trojanowski

Justin Trojanowski is recorded as CFO and Chief Accounting Officer at Tempest Therapeutics, Inc. (TPST). Tempest Therapeutics, Inc. reported in an 8-K filed August 24, 2026 that Justin Trojanowski resigned as Principal Financial Officer and Principal Accounting Officer, effective September 1, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed June 4, 2026 that Justin Trojanowski was appointed Vice President, Finance, Principal Financial Officer and Corporate Secretary, effective June 5, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed September 23, 2022 that Justin Trojanowski was appointed Corporate Controller, Treasurer and Principal Accounting Officer, effective September 30, 2022.

“On August 18, 2026, Mr. Justin Trojanowski notified Tempest Therapeutics, Inc. (the “Company”) of his decision to resign from his positions as Principal Financial Officer and Principal Accounting Officer of the Company, and from any and all other positions he holds with the Company, effective as of September 1, 2026.”
Tempest Therapeutics, Inc. Form 8-K, filed August 24, 2026 · Read the filing
“Effective June 5, 2026, the Board of Directors of the Company (the “Board”) appointed Mr. Justin Trojanowski as Vice President, Finance, Principal Financial Officer and Corporate Secretary of the Company, in addition to his current role as Corporate Controller, Treasurer and Principal Accounting Officer of the Company.”
Tempest Therapeutics, Inc. Form 8-K, filed June 4, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Tempest Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.